Insulin degludec Subcutaneous and NovoLog FlexPen
Determining the interaction of Insulin degludec Subcutaneous and NovoLog FlexPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin degludec
Brand name: Tresiba, Tresiba FlexTouch
Synonyms: Insulin degludec, Insulin Degludec
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin degludec Subcutaneous-Novolog Injection
- Insulin degludec Subcutaneous-NovoLog Mix 70/30
- Insulin degludec Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Insulin degludec Subcutaneous-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Insulin degludec Subcutaneous-NovoLog Mix 70/30 FlexPen
- Insulin degludec Subcutaneous-NovoLog PenFill
- NovoLog FlexPen-Insulin detemir
- NovoLog FlexPen-Insulin Detemir (Cartridges and Prefilled Syringes)
- NovoLog FlexPen-Insulin Detemir (Vials)
- NovoLog FlexPen-Insulin detemir Subcutaneous
- NovoLog FlexPen-Insulin glargine
- NovoLog FlexPen-Insulin Glargine (U-100) Cartridge Systems and Pens